Table 2

Knockdown of HPRT and treatment with 6TG allows for selection of primitive hematopoietic cells in secondary recipients

Donor treatmentby animal IDMean GFP%, 4 wk*
Mean GFP%, 8 wk (n)
WBCGr1B220WBCGr1B220
Background 0.08% 0.02% 0.03% 0.05% 0.02% 0.02% 
PBS       
    988 0.09% 0.01% 0.06% 0.07% (3) 0.04% (3) 0.02% (3) 
    989 0.09% 0.09% 0.05% 0.08% (3) 0.05% (2) 0.04% (2) 
    992       
    993 0.12% 0.01% 0.23% 0.08% (2) 0.05% (2) 0.03% (2) 
    995 0.08% 0.09% 0.02% 0.06% (2) 0.03 (2) 0.02% (2) 
Mean 0.10% 0.05% 0.09% 0.07% 0.04% 0.03% 
6TG       
    990 0.90% 0.08% 3.17% 0.14% (1) 0.02% (1) 0.49% (1) 
    991 7.03% 12.28% 3.25% 0.41% (3) 1.15% (3) 0.39% (3) 
    994 0.29% 0.11% 0.58% 0.08% (2) 0.03% (2) 0.09% (2) 
    996       
    997 10.20% 13.93% 1.86% 0.77% (3) 2.49% (3) 2.61% (3) 
Mean 4.61% 6.60% 2.22% 0.35% 0.92% 0.90% 
Donor treatmentby animal IDMean GFP%, 4 wk*
Mean GFP%, 8 wk (n)
WBCGr1B220WBCGr1B220
Background 0.08% 0.02% 0.03% 0.05% 0.02% 0.02% 
PBS       
    988 0.09% 0.01% 0.06% 0.07% (3) 0.04% (3) 0.02% (3) 
    989 0.09% 0.09% 0.05% 0.08% (3) 0.05% (2) 0.04% (2) 
    992       
    993 0.12% 0.01% 0.23% 0.08% (2) 0.05% (2) 0.03% (2) 
    995 0.08% 0.09% 0.02% 0.06% (2) 0.03 (2) 0.02% (2) 
Mean 0.10% 0.05% 0.09% 0.07% 0.04% 0.03% 
6TG       
    990 0.90% 0.08% 3.17% 0.14% (1) 0.02% (1) 0.49% (1) 
    991 7.03% 12.28% 3.25% 0.41% (3) 1.15% (3) 0.39% (3) 
    994 0.29% 0.11% 0.58% 0.08% (2) 0.03% (2) 0.09% (2) 
    996       
    997 10.20% 13.93% 1.86% 0.77% (3) 2.49% (3) 2.61% (3) 
Mean 4.61% 6.60% 2.22% 0.35% 0.92% 0.90% 

Flow cytometric data from peripheral blood of secondary recipients of BM from PBS- and 6TG-treated donors.

*

n = 3 secondary recipients per group.

or Create an Account

Close Modal
Close Modal